Skip to main content
Passa alla visualizzazione normale.

MAURIZIO SORESI

Safety and efficacy of Peginterferon (PEG-IFN) alpha 2 a(40 Kda) plus mycofenolatemofetile (MMF) and Peginterferon alpha 2 a plus Ribavirin (RBV) in unresponsive patients with chronic C hepatitis (CHC).

  • Authors: TRIPI S; DI GAETANO G; ALESSANDRI A; VUTURO O; SORESI M; SPADARO A; FRENI M; BRUNO S; SICILIANO R; MONTALTO G
  • Publication year: 2005
  • Type: eedings
  • OA Link: http://hdl.handle.net/10447/18848